FMT Placebo

OTHER3 trials

Sponsors

Aleris-Hamlet Hospitaler København, University of Birmingham, Consorcio Centro de Investigación Biomédica en Red (CIBER)

Conditions

Decompensated CirrhosisInflammatory Bowel DiseasesIrritable Bowel SyndromePrimary Sclerosing Cholangitis

Phase 2

Effect of Fecal Microbiota Transplantation in Irritable Bowel Syndrome

CompletedNCT02788071

Aleris-Hamlet Hospitaler KøbenhavnIrritable Bowel Syndrome

Start: 2016-10-31End: 2017-07-31Updated: 2017-08-02

FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis

RecruitingNCT06286709

University of BirminghamInflammatory Bowel Diseases, Primary Sclerosing Cholangitis

Start: 2024-03-27End: 2027-02-28Target: 58Updated: 2026-04-29

Phase 3

Fecal Microbiome Transplantation in Cirrhosis: Trial in Patients With Decompensated Cirrhosis

RecruitingNCT06533852

Consorcio Centro de Investigación Biomédica en Red (CIBER)Decompensated Cirrhosis

Start: 2025-07-16End: 2029-01-01Target: 190Updated: 2026-07-20

Related Papers

FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trial

BMJ Open2025-01-018 citations

The effect of faecal microbiota transplantation on abdominal pain, stool frequency, and stool form in patients with moderate-to-severe irritable bowel syndrome: results from a randomised, double-blind, placebo-controlled study.

2021-05-1723 citations

Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study

Gut2018-07-06326 citations